Prime Medicine, Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
PRME on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
60 First St., Cambridge, Massachusetts

Insiders trading volume in the past year

Prime Medicine, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
David R. Liu 10%+ Owner $302M Jul 21, 2023
Gv 2019 Gp, L.L.C. 10%+ Owner $178M Jun 20, 2023
Fmr Llc Other* $127M Oct 24, 2022
Robert Nelsen Director, 10%+ Owner $96.7M +$20M +26.1% Jun 12, 2024
ARCH Venture Partners XII, LLC 10%+ Owner $96.6M +$20M +26.1% Feb 15, 2024
ARCH Venture Partners X, LLC 10%+ Owner $96.6M +$20M +26.1% Feb 15, 2024
Keith Michael Gottesdiener President and Chief Executive Officer, Director $24.4M Jun 5, 2024
Gv 2023 Gp, L.L.C. Member of 10% Group $20M Feb 20, 2024
Jeffrey D. Marrazzo Director Jun 12, 2024
David Schenkein Director Jun 12, 2024
Kaye I. Foster-Cheek Director Jun 12, 2024
Ann L. Lee Chief Technical Officer May 17, 2024
Wendy Chung Director Jun 12, 2024
Jeremy Duffield Chief Scientific Officer Feb 21, 2024
Thomas Cahill Director Jun 12, 2024
Meredith Goldwasser SVP, Strategy & Corporate Ops. Feb 21, 2024
Richard Brudnick Chief Business Officer May 17, 2024
Carman Alenson SVP, Finance and Chief Accounting Officer Feb 21, 2024
Allan Reine Chief Financial Officer May 17, 2024
Michael Aaron Kelly Director Jun 12, 2024

Recent Insider Transactions by Companies or Individuals for Prime Medicine, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.